Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81 | 50 | 33 | 49 | 101 |
| Inventories | 2 | 40 | 40 | 40 | 40 |
| TOTAL | $89 | $92 | $76 | $92 | $141 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | 1 | 1 |
| TOTAL | $1 | $1 | $1 | $1 | $1 |
| Total Assets | $90 | $93 | $77 | $93 | $142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 155 | 113 | 91 | 116 | 114 |
| Accounts payable and accrued liabilities | 367 | 377 | 367 | 367 | 486 |
| Accrued Expenses | 227 | 225 | 225 | 228 | 228 |
| TOTAL | $749 | $715 | $682 | $710 | $828 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $749 | $715 | $682 | $710 | $828 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 445,493 | 383,120 | 319,440 | 225,634 | 210,301 |
| Common Shares | 436 | 383 | 304 | 210 | 171 |
| Retained earnings | -7,215 | -7,041 | -6,953 | -6,835 | -6,674 |
| TOTAL | $-659 | $-621 | $-605 | $-617 | $-685 |
| Total Liabilities And Equity | $90 | $93 | $77 | $93 | $142 |